Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

François Maignen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Drug Safety|April 20, 2010
Modelling the time to onset of adverse reactions with parametric survival distributions: a potential approach to signal detection and evaluationFrançois Maignen, Manfred Hauben, Panos Tsintis
Therapeutic Advances in Drug Safety|August 29, 2017
A mathematical framework to quantify the masking effect associated with the confidence intervals of measures of disproportionalityFrançois Maignen, Manfred Hauben, Jean-Michel Dogné
European Journal of Clinical Pharmacology|December 13, 2016
Integrating health technology assessment requirements in the clinical development of medicines: the experience from NICE scientific adviceFrançois Maignen, Leeza Osipenko, Pilar Pinilla-Dominguez, et al.
International Journal of Biological Macromolecules|June 25, 2023
The effects of biliverdin on pressure-induced unfolding of apomyoglobin: The specific role of Zn<sup>2+</sup> ionsSimeon Minic, Burkhard Annighöfer, Milos Milcic, et al.
Molecular Oncology|December 19, 2018
Late translational research: putting forward a new model for developing new anti-cancer treatments that addresses the needs of patients and societyDenis Lacombe, Jan Bogaerts, Bertrand Tombal, et al.
Acta Haematologica|May 11, 2012
A case of therapy-related myeloid neoplasm in a patient with Crohn's disease treated with azathioprineFrançois Mullier, Jean-François Rahier, François Maignen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Drug Safety|April 20, 2010
Modelling the time to onset of adverse reactions with parametric survival distributions: a potential approach to signal detection and evaluationFrançois Maignen, Manfred Hauben, Panos Tsintis
Therapeutic Advances in Drug Safety|August 29, 2017
A mathematical framework to quantify the masking effect associated with the confidence intervals of measures of disproportionalityFrançois Maignen, Manfred Hauben, Jean-Michel Dogné
European Journal of Clinical Pharmacology|December 13, 2016
Integrating health technology assessment requirements in the clinical development of medicines: the experience from NICE scientific adviceFrançois Maignen, Leeza Osipenko, Pilar Pinilla-Dominguez, et al.
International Journal of Biological Macromolecules|June 25, 2023
The effects of biliverdin on pressure-induced unfolding of apomyoglobin: The specific role of Zn<sup>2+</sup> ionsSimeon Minic, Burkhard Annighöfer, Milos Milcic, et al.
Molecular Oncology|December 19, 2018
Late translational research: putting forward a new model for developing new anti-cancer treatments that addresses the needs of patients and societyDenis Lacombe, Jan Bogaerts, Bertrand Tombal, et al.
Acta Haematologica|May 11, 2012
A case of therapy-related myeloid neoplasm in a patient with Crohn's disease treated with azathioprineFrançois Mullier, Jean-François Rahier, François Maignen, et al.
Pageof 1